HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Casiraghi Selected Research

Neoplasms (Cancer)

11/2021Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics.
1/2020Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
1/2020ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.
11/2015Plasma AR and abiraterone-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicola Casiraghi Research Topics

Disease

4Neoplasms (Cancer)
11/2021 - 11/2015
3Prostatic Neoplasms (Prostate Cancer)
01/2020 - 11/2015
1Multiple Myeloma
11/2021
1Adenocarcinoma
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Scrapie
11/2013
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2013

Drug/Important Bio-Agent (IBA)

2Circulating Tumor DNAIBA
01/2020 - 01/2020
2Cell-Free Nucleic AcidsIBA
01/2020 - 01/2020
2Androgen Receptors (Androgen Receptor)IBA
01/2020 - 11/2015
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 11/2015
1RNA (Ribonucleic Acid)IBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1hydrogen sulfite (bisulfite)IBA
01/2020
1NucleotidesIBA
01/2020
1Hormones (Hormone)IBA
11/2015
1abirateroneIBA
11/2015
1Amino AcidsFDA Link
11/2015
1Prion ProteinsIBA
11/2013
1Protein Isoforms (Isoforms)IBA
11/2013

Therapy/Procedure

3Castration
01/2020 - 11/2015
1Aftercare (After-Treatment)
11/2021